Kidney disease does not automatically rule out PRP for a joint or tendon, but it changes how the decision is made. A 2025 international consensus says PRP may be considered in people on dialysis, with careful monitoring for infection and never on a dialysis day. The right answer depends on the diagnosis, the likely benefit, your kidney team's plan and your medicines.
Key points
A 2025 formal consensus from the International Research Group on Platelet Injections, published in Knee Surgery, Sports Traumatology, Arthroscopy, states PRP may be considered in chronic kidney failure requiring dialysis.
The same consensus advises that injection must be avoided on the day of dialysis and that patients are monitored for bloodstream infection, rated a Grade C recommendation.
Joint PRP evidence is strongest for tennis elbow, where a 2025 Level I meta-analysis of 26 randomised trials found PRP better than steroid beyond six months.
For knee osteoarthritis the evidence is contested, and a 2021 randomised trial in JAMA found PRP no better than placebo.
Ask a doctor about joint PRP with kidney disease&type=phone_number&app_absent=0) or email team@thewellnesslondon.com.
What does the PRP guidance say about dialysis?
The most specific guidance comes from the 2025 consensus of the International Research Group on Platelet Injections, known by its French acronym GRIIP. A panel of rheumatologists, haematologists, infection specialists and sports physicians reviewed when PRP should and should not be used in people with infectious, cancer-related and blood-related conditions.
On dialysis, the panel's position is cautious but not prohibitive. PRP injection may be considered in people with chronic kidney failure who need dialysis. They should be carefully monitored for signs of bacteria in the bloodstream, and the injection must not be given on a dialysis day.
That recommendation was graded C, meaning it rests mainly on expert agreement rather than trial data. Very few people on dialysis have been included in PRP studies. The honest reading is that PRP is possible with planning, not that it has been proven safe and effective for this group.
It is also worth being clear about scope. This guidance concerns joint and tendon injections. It does not tell us anything about scalp or facial PRP in kidney disease, which need their own assessment.
Does the same apply to everyone with chronic kidney disease?
Chronic kidney disease ranges from mildly reduced filtration with no symptoms to kidney failure requiring dialysis or a transplant. The questions a doctor asks change across that range.
In early disease, the main considerations are the same as for anyone else. Is the diagnosis right, is PRP likely to help, and are any medicines relevant. Many people with stage 2 or 3 disease have no additional restrictions.
In advanced disease, two further issues matter. Uraemia can impair platelet function, which affects both bleeding risk and, in theory, the quality of the platelets used for treatment. Anaemia is common and may change how much blood can sensibly be drawn.
After a kidney transplant, immunosuppressive medicine raises infection risk, and the transplant team's view becomes essential. Steroid-sparing regimes, antiplatelet medicines and anticoagulants all need checking.
Our doctors therefore ask for your most recent eGFR, haemoglobin and platelet count, and for a summary from your kidney team if you have one.
Why do medicines and the dialysis schedule matter?
People on haemodialysis usually receive heparin during each session to stop the circuit clotting. Its effect wears off within hours, but an injection given the same day carries more bleeding risk. This is part of the reason the consensus advises against same-day treatment.
Many people with kidney disease also take aspirin, clopidogrel or an anticoagulant for heart or vascular reasons. These are never stopped for an elective injection without agreement from the prescribing team. Stopping them for a joint procedure can carry a far greater risk than the pain being treated.
Non-steroidal anti-inflammatory drugs such as ibuprofen are usually avoided around PRP anyway, because they may blunt the platelet response. In kidney disease they are often avoided altogether because they can harm remaining kidney function.
Fistulas and grafts matter practically. Blood for PRP is never drawn from a dialysis access arm, and the opposite arm is used.
Send us your medicine list for a doctor's review&type=phone_number&app_absent=0)
Why is infection an important part of the review?
People on dialysis have a higher risk of bloodstream infection, particularly with central venous catheters. Any procedure that breaks the skin over a joint carries a small risk of introducing infection, and a joint infection is a serious complication in anyone.
The consensus focus on monitoring reflects that. In practice, our doctors will not treat while there is any sign of active infection, including a recent line infection, a skin infection near the site or an unexplained fever.
Strict aseptic technique and ultrasound guidance reduce the chance of a misplaced injection and of repeat needle passes. After treatment, you will be told exactly which symptoms need same-day attention.
A hot, red, swollen joint with fever after any injection is an emergency. It needs urgent assessment, not a routine follow-up. We cover this in our guide to a hot swollen joint after PRP.
A free checklist to bring to any joint injection appointment
Whether you see us, your NHS team or another clinic, these are the points that make a joint injection safer with kidney disease. Bring the answers with you.
Your diagnosis for the painful joint, and how it was confirmed, ideally with an ultrasound or MRI report.
Your latest eGFR, haemoglobin and platelet count, with dates.
Your dialysis type, days and usual session times, and where your access is.
Every medicine you take, especially aspirin, clopidogrel, warfarin, apixaban, rivaroxaban, steroids and immunosuppressants.
Any infections in the last three months, including line or fistula infections.
The name and contact of your kidney team, and whether they are happy for an elective injection to go ahead.
What you hope the injection will achieve, so the doctor can tell you whether that is realistic.
Ask the clinician three questions. Is the diagnosis certain. What is the evidence for PRP in this specific condition. What would you do instead if PRP were not an option.
What does a useful suitability assessment bring together?
A good assessment answers whether PRP is the right treatment before it asks whether it is safe. For many joint problems in people with kidney disease, the pain has another explanation. Gout and pseudogout are more common in kidney disease and are treated differently. Dialysis-related amyloid can affect the shoulders and wrists. Bone changes from mineral disorders can mimic joint pain.
The doctor examines the joint, reviews imaging and, where needed, performs a diagnostic ultrasound. If the diagnosis is tendon degeneration, such as tennis elbow or a chronic gluteal tendon problem, PRP evidence is reasonable. If it is advanced knee arthritis, the expected benefit is smaller and the decision more finely balanced.
As our doctors put it, "With kidney disease, the safest injection is often the one we decide not to give. Getting the diagnosis right comes before choosing the needle."
What should be clear before a treatment date is agreed?
Before any date is set, you should know the diagnosis, the evidence for PRP in that condition, the number of injections being proposed and why, and how success will be measured.
For dialysis patients, the date must fall on a non-dialysis day, ideally with a dialysis-free day after it so any reaction can be seen. Your kidney team should know the plan. Bloods should be recent enough to reflect your current state.
You should also understand that a single injection may be all that is advised. In hip osteoarthritis, research suggests a single injection may outperform multiple, and the same restraint is sensible when every procedure carries extra risk.
What PRP cannot do in kidney disease
PRP does not treat kidney disease, gout, amyloid or bone mineral problems. If one of those is causing the joint pain, PRP will not help.
The evidence for PRP in people on dialysis is very limited. The consensus recommendation rests mainly on expert opinion.
Knee osteoarthritis evidence is contested. A 2023 meta-analysis of 30 studies with 2,733 patients favoured PRP over hyaluronic acid, but a 2021 randomised trial in JAMA found it no better than placebo, and NICE describes the evidence as limited in quality.
PRP is not suitable during active infection, with uncontrolled bleeding problems or with a very low platelet count.
What does joint PRP cost in London?
Specialist central London clinics commonly charge from around £780 to £900 or more per image-guided joint or tendon injection including assessment. A course of two to three injections takes a plan past £2,000. Elsewhere in the UK, injections are advertised from roughly £250 to £500. PRP is not routinely commissioned by the NHS, and private insurance rarely covers it.
The lower prices usually leave out the parts that matter most with kidney disease. No image guidance, little doctor time, and no review of medicines and dialysis timing. Those are not optional extras in this situation.
Our care is doctor-led, ultrasound-guided and priced below flagship rates. The figure is confirmed at your free suitability review.
Message us about joint PRP&type=phone_number&app_absent=0) or email team@thewellnesslondon.com.
Your free suitability review
Every enquiry starts with a free doctor-led suitability review rather than a booking. A GMC-registered doctor assesses you and gives one of two answers. Approved for treatment, with a clear plan and realistic expectations, or not approved, with an honest explanation of what would serve you better. We decline a meaningful share of enquiries, because treating someone who will not benefit helps nobody.
With kidney disease, we will often ask for a letter or results from your kidney team before deciding. If PRP is not the right choice, the doctor will explain what would help instead.
Why people choose The London PRP Clinic by The Wellness
87 percent patient success rate across our treatment outcomes.
32 percent average density increase in hair restoration.
More than 187 five-star reviews.
Every treatment is performed by a GMC-registered doctor.
100 supervised treatments before any clinician treats a patient here.
Start your free joint PRP suitability review&type=phone_number&app_absent=0)
Frequently asked questions
Can I have PRP if I am on dialysis?
Possibly. A 2025 international consensus says PRP may be considered in people on dialysis, with monitoring for bloodstream infection and never on a dialysis day. It is a cautious, expert-based recommendation, so a doctor must review your diagnosis, medicines and kidney team plan first.
Is PRP safe with chronic kidney disease?
In early chronic kidney disease, PRP usually carries no extra restrictions beyond a normal assessment. In advanced disease, platelet function, anaemia, infection risk and medicines need checking. The decision should involve your kidney team, especially after a transplant or with anticoagulation.
Why can PRP not be given on a dialysis day?
Haemodialysis usually involves heparin to stop the circuit clotting, which raises bleeding risk for a few hours. Dialysis patients also have a higher infection risk. The 2025 consensus advises avoiding injection on dialysis days so any reaction can be watched safely.
Should I stop blood thinners before joint PRP?
No, not without agreement from the doctor who prescribed them. Stopping aspirin, clopidogrel or an anticoagulant for an elective injection can carry more risk than the joint pain itself. Your doctor will plan around your medicines rather than change them unilaterally.
Does PRP work for knee arthritis?
The evidence is contested. Some meta-analyses show better function than hyaluronic acid, but a 2021 randomised trial in JAMA found PRP no better than placebo, and NICE calls the evidence limited in quality. Results vary, so expectations should be realistic.
What joint problems respond best to PRP?
Tennis elbow has the strongest evidence, with a 2025 meta-analysis of 26 randomised trials showing PRP better than steroid beyond six months. Plantar fasciitis also shows good long-term results. Knee and hip arthritis and Achilles problems have more mixed evidence.
This article is general information and does not replace a consultation with a doctor. If you have sudden severe pain, a hot swollen joint, fever or rapidly spreading redness, seek urgent medical care or call 999.
Reviewed by [GMC-REGISTERED DOCTOR NAME, GMC NUMBER TO CONFIRM], The London PRP Clinic by The Wellness. Last updated November 2026.